Prevalence of thalassemia in patients with microcytosis referred for hemoglobinopathy investigation in Ontario: A prospective cohort study

American Journal of Clinical Pathology

Volumn 127, Issue 2, 2007, Pages 192-196

  Lafferty, John D ^a   Barth, David S ^b   Sheridan, Brian L ^c   McFarlane, Andrew G ^d   Halchuk, Linda M ^d   Crowther, Mark A ^a,e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MDS Laboratories   (Canada)

^d HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^e ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Hemoglobinopathy; Microcytic anemia; Prevalence; Thalassemia

Indexed keywords

ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA EXTRACTION; HEMOGLOBINOPATHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MICROCYTOSIS; PREVALENCE; PRIORITY JOURNAL; THALASSEMIA; ADOLESCENT; ALPHA THALASSEMIA; BETA THALASSEMIA; BLOOD; COHORT ANALYSIS; CYTOLOGY; ERYTHROCYTE DISORDER; ETHNOLOGY; GENETICS; HEMOGLOBIN DETERMINATION; IRON DEFICIENCY ANEMIA; MULTICENTER STUDY; PROSPECTIVE STUDY;

ADOLESCENT; ALPHA-THALASSEMIA; ANEMIA, IRON-DEFICIENCY; BETA-THALASSEMIA; COHORT STUDIES; ERYTHROCYTES, ABNORMAL; HEMOGLOBINOMETRY; HEMOGLOBINOPATHIES; HUMANS; ONTARIO; PREVALENCE; PROSPECTIVE STUDIES;

EID: 33847064732     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/P6HM33F4D05T30YM     Document Type: Article

References (18)

1. Dumars KW, Boehm C, Eckman JR, et al. Practical guide to the diagnosis of thalassemia. Am J Med Gen. 1996;62:29-37.
2. Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353:1135-1146.
3. Lafferty J, Waye JS, Chui DH, et al. Good practice guidelines for laboratory investigation of hemoglobinopathies. Lab Hematol. 2003;9:237-245.
4. Weatherall DJ. The thalassemias: the role of molecular genetics in an evolving global health problem. Am J Hum Genet. 2004;74:385-392.
5. Waye JS, Chui DHK. The alpha-globin gene cluster: genetics and disorders. Clin Invest Med. 2001;24:103-109.
6. Olivieri N. The β thalassemias. N Engl J Med. 1999;341:99-109.
7. Chui DHK, Waye JS. Hydrops fetalis caused by α thalassemia: an emerging health care problem. Blood. 1998;91:2213-2222.
8. Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101:791-800.
9. Modell M, Modell B. Genetic screening for ethnic minorities. Br Med J. 1990;300:1702-1704.
10. Lafferty J. The laboratory diagnosis of a thalassemia. Can J Med Lab Sci. 1998;60:183-189.
11. Bain BJ, Amos RJ, Bareford D, et al. Guideline: the laboratory diagnosis of haemoglobinopathies. Br J Haematol. 1998;101:783-792.
12. Dacie JV, Lewis SM. Investigations of abnormal haemoglobins and thalassemia. In: Practical Haematology. 6th ed. Edinburgh, Scotland: Churchill Livingstone; 1995:283-284.
13. United Biotech. α-Thalassemia (-SEA) ζ Globin Enzyme Immunoassay [package insert]. Mountain View, CA: United Biotech; 2005.
14. 0-thalassemia deletion: detection of embryonic zeta-globin chains by enzyme-linked immunosorbent assay. Am J Clin Pathol. 2000;114:927-931.
15. Lafferty JD, Crowther MA, Ali MAM, et al. The evaluation of various mathematical indices and their efficacy in discriminating between thalassemic and nonthalassemic microcytosis. Am J Clin Pathol. 1996:106:201-205.
16. Ali MAM, Lafferty J. The clinical significance of hemoglobinopathies in the Hamilton region: a twenty year review. Clin Invest Med. 1992;15:401-405.
17. Bergeron J, Weng X, Robin L, et al. Prevalence of α-globin gene deletions among patients with unexplained microcytosis in a North American population. Hemoglobin. 2005;29:51-60.
18. Basran RK, Patterson M, Walker L, et al. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada. Ann N Y Acad Sci. 2005;1054:507-510.